• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四种人乳头瘤病毒L1衣壳蛋白的晶体结构:了解中和单克隆抗体的特异性

Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies.

作者信息

Bishop Brooke, Dasgupta Jhimli, Klein Michael, Garcea Robert L, Christensen Neil D, Zhao Rui, Chen Xiaojiang S

机构信息

Department of Molecular and Computational Biology, University of Southern California, Los Angeles, California 90089, USA.

出版信息

J Biol Chem. 2007 Oct 26;282(43):31803-11. doi: 10.1074/jbc.M706380200. Epub 2007 Sep 4.

DOI:10.1074/jbc.M706380200
PMID:17804402
Abstract

Human papillomaviruses (HPVs) are known etiologic agents of cervical cancer. Vaccines that contain virus-like particles (VLPs) made of L1 capsid protein from several high risk HPV types have proven to be effective against HPV infections. Raising high levels of neutralizing antibodies against each HPV type is believed to be the primary mechanism of protection, gained by vaccination. Antibodies elicited by a particular HPV type are highly specific to that particular HPV type and show little or no cross-reactivity between HPV types. With an intention to understand the interplay between the L1 structure of different HPV types and the type specificity of neutralizing antibodies, we have prepared the L1 pentamers of four different HPV types, HPV11, HPV16, HPV18, and HPV35. The pentamers only bind the type-specific neutralizing monoclonal antibodies (NmAbs) that are raised against the VLP of the corresponding HPV type, implying that the surface loop structures of the pentamers from each type are distinctive and functionally active as VLPs in terms of antibody binding. We have determined the crystal structures of all four L1 pentamers, and their comparisons revealed characteristic conformational differences of the surface loops that contain the known epitopes for the NmAbs. On the basis of these distinct surface loop structures, we have provided a molecular explanation for the type specificity of NmAbs against HPV infection.

摘要

人乳头瘤病毒(HPV)是宫颈癌已知的病原体。含有由几种高危型HPV的L1衣壳蛋白制成的病毒样颗粒(VLP)的疫苗已被证明对HPV感染有效。产生针对每种HPV类型的高水平中和抗体被认为是疫苗接种获得保护的主要机制。由特定HPV类型引发的抗体对该特定HPV类型具有高度特异性,并且在不同HPV类型之间几乎没有或没有交叉反应性。为了了解不同HPV类型的L1结构与中和抗体的类型特异性之间的相互作用,我们制备了四种不同HPV类型(HPV11、HPV16、HPV18和HPV35)的L1五聚体。这些五聚体仅与针对相应HPV类型的VLP产生的类型特异性中和单克隆抗体(NmAb)结合,这意味着每种类型的五聚体的表面环结构是独特的,并且在抗体结合方面作为VLP具有功能活性。我们已经确定了所有四种L1五聚体的晶体结构,它们的比较揭示了包含已知NmAb表位的表面环的特征性构象差异。基于这些独特的表面环结构,我们对针对HPV感染的NmAb的类型特异性提供了分子解释。

相似文献

1
Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies.四种人乳头瘤病毒L1衣壳蛋白的晶体结构:了解中和单克隆抗体的特异性
J Biol Chem. 2007 Oct 26;282(43):31803-11. doi: 10.1074/jbc.M706380200. Epub 2007 Sep 4.
2
Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.由L1/L2嵌合病毒样颗粒组成的人乳头瘤病毒疫苗在临床前模型中诱导产生广泛的交叉保护作用。
J Virol. 2016 Jun 24;90(14):6314-25. doi: 10.1128/JVI.00449-16. Print 2016 Jul 15.
3
Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33.人乳头瘤病毒33型主要衣壳蛋白中中和表位的特性分析
Virol J. 2006 Oct 2;3:83. doi: 10.1186/1743-422X-3-83.
4
Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity.人乳头瘤病毒样颗粒的拆卸和组装产生更多类似病毒的抗体反应性。
Virol J. 2012 Feb 22;9:52. doi: 10.1186/1743-422X-9-52.
5
Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies.人乳头瘤病毒16型主要衣壳蛋白FG表面环上的突变会影响型特异性中和抗体和交叉反应抗体的识别。
J Med Virol. 2005 Dec;77(4):558-65. doi: 10.1002/jmv.20492.
6
Identification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31.人乳头瘤病毒31型主要衣壳蛋白上型特异性和交叉反应性中和构象表位的鉴定
Arch Virol. 2006 Aug;151(8):1511-23. doi: 10.1007/s00705-006-0734-y. Epub 2006 Mar 3.
7
Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.杂交乳头瘤病毒L1分子组装成病毒样颗粒,这些颗粒可重构构象表位并诱导针对不同HPV类型的中和抗体。
Virology. 2001 Dec 20;291(2):324-34. doi: 10.1006/viro.2001.1220.
8
Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.呈现人乳头瘤病毒6型(HPV-6)和人乳头瘤病毒16型(HPV-16)次要衣壳蛋白L2共同中和表位的嵌合人乳头瘤病毒16型(HPV-16)L1颗粒。
J Virol. 2003 Aug;77(15):8386-93. doi: 10.1128/jvi.77.15.8386-8393.2003.
9
Type-specific and cross-reactive antibodies induced by human papillomavirus 31 L1/L2 virus-like particles.人乳头瘤病毒31型L1/L2病毒样颗粒诱导的型特异性和交叉反应性抗体。
J Med Microbiol. 2007 Jul;56(Pt 7):907-913. doi: 10.1099/jmm.0.47073-0.
10
Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.全面评估人乳头瘤病毒谱系变异对基于疫苗相关基因型主要衣壳蛋白的中和单克隆抗体识别的抗原性影响
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.01236-20.

引用本文的文献

1
Intratype variants and high genotypic diversity of human papillomavirus with polymorphisms in the antigenic hypervariable loops of the L1 protein from women living with human immunodeficiency virus in Northeastern Brazil.巴西东北部感染人类免疫缺陷病毒女性的人乳头瘤病毒的型内变体、高基因型多样性以及L1蛋白抗原高变环中的多态性
J Med Microbiol. 2025 Mar;74(3). doi: 10.1099/jmm.0.001981.
2
Scientific approaches to defining HPV vaccine-induced protective immunity.定义HPV疫苗诱导的保护性免疫的科学方法。
Int J Cancer. 2025 May 15;156(10):1848-1857. doi: 10.1002/ijc.35345. Epub 2025 Feb 13.
3
Rational design of a triple-type HPV53/56/66 vaccine with one preferable base particle incorporating two identified immunodominant sites.
一种三联型HPV53/56/66疫苗的合理设计,该疫苗具有一个包含两个已确定免疫显性位点的优选基础颗粒。
J Nanobiotechnology. 2025 Jan 20;23(1):28. doi: 10.1186/s12951-024-03080-5.
4
Dissociation of Macromolecules in Laser-Heated Droplets Monitored by CD-MS.通过圆二色质谱法监测激光加热液滴中大分子的解离
Anal Chem. 2025 Jan 21;97(2):1419-1425. doi: 10.1021/acs.analchem.4c06038. Epub 2025 Jan 7.
5
The full transcription map of cottontail rabbit papillomavirus in tumor tissues.棉尾兔乳头瘤病毒在肿瘤组织中的全转录图谱。
PLoS Pathog. 2024 Oct 25;20(10):e1012649. doi: 10.1371/journal.ppat.1012649. eCollection 2024 Oct.
6
Design and antiviral assessment of a panel of fusion proteins targeting human papillomavirus type 16.设计并评估一组针对人乳头瘤病毒 16 型的融合蛋白。
PLoS One. 2024 Oct 25;19(10):e0311137. doi: 10.1371/journal.pone.0311137. eCollection 2024.
7
Enhancing the therapeutic potential of P29 protein-targeted monoclonal antibodies in the management of alveolar echinococcosis through CDC-mediated mechanisms.通过 CDC 介导的机制增强 P29 蛋白靶向单克隆抗体在泡型包虫病治疗中的潜力。
PLoS Pathog. 2024 Aug 23;20(8):e1012479. doi: 10.1371/journal.ppat.1012479. eCollection 2024 Aug.
8
A Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt Adjuvant.一种结合液相色谱-质谱联用和免疫分析的方法来表征吸附于铝盐佐剂的人乳头瘤病毒样颗粒中防腐剂诱导的稳定性破坏
Vaccines (Basel). 2024 May 26;12(6):580. doi: 10.3390/vaccines12060580.
9
Lineage Replacement and Genetic Changes of Four HR-HPV Types during the Period of Vaccine Coverage: A Six-Year Retrospective Study in Eastern China.疫苗接种期间四种高危型人乳头瘤病毒的谱系替代和基因变化:中国东部地区的一项六年回顾性研究
Vaccines (Basel). 2024 Apr 12;12(4):411. doi: 10.3390/vaccines12040411.
10
Global evaluation of lineage-specific human papillomavirus capsid antigenicity using antibodies elicited by natural infection.利用自然感染诱导的抗体对人乳头瘤病毒衣壳抗原的种系特异性进行全球评估。
Nat Commun. 2024 Feb 21;15(1):1608. doi: 10.1038/s41467-024-45807-w.